» Articles » PMID: 35836045

Pseudoscience And fraudulent Products for COVID-19 Management

Overview
Publisher Springer
Date 2022 Jul 14
PMID 35836045
Authors
Affiliations
Soon will be listed here.
Abstract

As of now, the COVID-19 pandemic has become uncontrolled and is spreading widely throughout the world. Additionally, new variants of the mutated viral variants have been found in some countries that are more dangerous than the original strain. Even vaccines cannot produce complete protective immunity against the newer strains of SARS-CoV-2. Due to such a dreadful situation, lots of fear and depression have been created among the public. People are looking for the treatment of the disease at any cost and there is a race in the market to provide treatment and make money, whether it is effective or not! In such a condition, many fraud products, remedies, and myths have come into the market, which is falsely claimed to be effective for the disease and can harm the patients. Hence, FDA has banned such products and remedies. In this review, we have compiled all such fraudulent and pseudosciences identified for COVID-19. Currently, in the pandemic time, health agencies are approving the repurposed medicines based on the small-scale clinical data for emergency uses that become ineffective (most of the cases) after large randomized clinical studies. Proper vigilance strategies need to be defined by the regulatory agencies of the nation and routine awareness programs shall be arranged for educating the people and healthcare workers on routine updates.

Citing Articles

Deciphering the Roots of Pharmacists' Critical Thinking About Pseudoscientific Claims: Insights from a Cross-Sectional Survey.

Watanabe T, Matsumoto M, Ukawa M, Ohira M, Tsunoda M Pharmacy (Basel). 2024; 12(6).

PMID: 39585091 PMC: 11587478. DOI: 10.3390/pharmacy12060165.


Unlocking insights: Navigating COVID-19 challenges and Emulating future pandemic Resilience strategies with strengthening natural immunity.

Wimalawansa S Heliyon. 2024; 10(15):e34691.

PMID: 39166024 PMC: 11334859. DOI: 10.1016/j.heliyon.2024.e34691.


Microbes and us: microbiology literacy in Greece.

Karayanni H, Motsiou E, Sapountzi V, Meggou L, Pagkoutsou M, Triantafyllidi A FEMS Microbiol Lett. 2024; 371.

PMID: 38305148 PMC: 10878407. DOI: 10.1093/femsle/fnae008.


Demographic and psychometric predictors associated with engagement in risk-associated alternative healthcare behaviours.

Garrett B, Caulfield T, Musoke R, Murdoch B, Tang X, Lam J PLoS One. 2023; 18(9):e0291016.

PMID: 37733748 PMC: 10513319. DOI: 10.1371/journal.pone.0291016.


Black Salve (or escharotics). A picture about an unorthodox medical preparation in oncology.

Borkens Y Skin Health Dis. 2023; 3(3):e241.

PMID: 37275421 PMC: 10233163. DOI: 10.1002/ski2.241.


References
1.
Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

2.
Huang X, Shao X, Xing L, Hu Y, Sin D, Zhang X . The impact of lockdown timing on COVID-19 transmission across US counties. EClinicalMedicine. 2021; 38:101035. PMC: 8283304. DOI: 10.1016/j.eclinm.2021.101035. View

3.
Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

4.
Grimes D . Medical disinformation and the unviable nature of COVID-19 conspiracy theories. PLoS One. 2021; 16(3):e0245900. PMC: 7954317. DOI: 10.1371/journal.pone.0245900. View

5.
Marwitz K . The pharmacist's active role in combating COVID-19 medication misinformation. J Am Pharm Assoc (2003). 2020; 61(2):e71-e74. PMC: 7640945. DOI: 10.1016/j.japh.2020.10.022. View